Vivoryon Therapeutics N.V. - Neraca (Quarterly)

Vivoryon Therapeutics N.V.
GB ˙ LSE ˙ NL00150002Q7
Talaan ng Balanse (Quarterly)

Neraca Vivoryon Therapeutics N.V. menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Cash 26 20 20 20 15 24 24 27 27 30 30 19 19 15 15 9 9 5 5
Change (%) -24.61 0.00 0.15 -26.18 66.31 0.00 8.91 0.00 11.40 0.00 -37.25 0.00 -17.72 0.00 -38.68 0.00 -48.35 0.00
Assets Current 29 22 22 29 20 31 31 31 31 45 45 30 30 16 16 10 10 5 5
Change (%) -23.14 0.00 28.84 -29.05 53.20 0.00 -0.96 0.00 45.77 0.00 -33.37 0.00 -46.17 0.00 -37.27 0.00 -47.91 0.00
Assets 30 23 23 29 25 32 32 31 31 45 45 31 31 17 17 11 11 6 6
Change (%) -22.55 0.00 27.54 -16.56 29.46 0.00 -1.15 0.00 44.54 0.00 -32.03 0.00 -44.89 0.00 -33.59 0.00 -43.11 0.00
Liabilities 4 8 8 8 8 7 7 5 5 4 4 5 5 3 3 3 3 3 3
Change (%) 114.45 0.00 9.19 -3.67 -18.30 0.00 -25.12 0.00 -21.57 0.00 19.00 0.00 -33.78 0.00 13.05 0.00 -4.88 0.00
Equity 26 15 15 21 17 25 25 27 27 42 42 26 26 14 14 8 8 3 3
Change (%) -41.00 0.00 36.51 -21.61 52.42 0.00 5.03 0.00 56.70 0.00 -36.72 0.00 -46.81 0.00 -43.63 0.00 -59.63 0.00
Liabilities And Stock Equity 30 23 23 29 25 32 32 31 31 45 45 31 31 17 17 11 11 6 6
Change (%) -22.55 0.00 27.54 -16.56 29.46 0.00 -1.15 0.00 44.54 0.00 -32.03 0.00 -44.89 0.00 -33.59 0.00 -43.11 0.00

Source: Capital IQ

Other Listings
AT:VVYN
NL:VVY € 1.64
GB:VVYA
DE:05Y € 1.61
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista